A Genetic ‘fingerprint’ may ID breast cancer patients likely to benefit from potentially toxic chemo, study finds. Conversely, we could avoid these drugs if we knew a patient was unlikely to benefit from their use.

If you would like to read more about this study via Stanford Medicine, click the link below.